These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19098221)

  • 21. A mutated cytosine deaminase gene, codA (D314A), as an efficient negative selection marker for gene targeting in rice.
    Osakabe K; Nishizawa-Yokoi A; Ohtsuki N; Osakabe Y; Toki S
    Plant Cell Physiol; 2014 Mar; 55(3):658-65. PubMed ID: 24371307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bystander effect from cytosine deaminase and uracil phosphoribosyl transferase genes in vitro: a partial contribution of gap junctions.
    Tanaka T; Duflot-Dancer A; Tiraby M; Piccoli C; Tiraby G; Yamasaki H; Mesnil M
    Cancer Lett; 2009 Sep; 282(1):43-7. PubMed ID: 19342154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression.
    Dubois L; Dresselaers T; Landuyt W; Paesmans K; Mengesha A; Wouters BG; Van Hecke P; Theys J; Lambin P
    Br J Cancer; 2007 Mar; 96(5):758-61. PubMed ID: 17311022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of a gene encoding cytosine deaminase in the genome of the agaricomycete Coprinopsis cinerea enables simple marker recycling through 5-fluorocytosine counterselection.
    Nakazawa T; Honda Y
    FEMS Microbiol Lett; 2015 Aug; 362(15):fnv123. PubMed ID: 26223587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine.
    Fox BA; Belperron AA; Bzik DJ
    Mol Biochem Parasitol; 1999 Jan; 98(1):93-103. PubMed ID: 10029312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
    Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
    Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implication of functional activity for determining therapeutic efficacy of suicide genes in vitro.
    Gopinath P; Ghosh SS
    Biotechnol Lett; 2008 Nov; 30(11):1913-21. PubMed ID: 18594769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
    Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
    Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
    Sun CH; Berg K; Hirschberg H
    Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
    Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
    J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
    Pastorakova A; Hlubinova K; Altaner C
    Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Van Rite BD; Harrison RG
    Cancer Lett; 2011 Aug; 307(1):53-61. PubMed ID: 21546157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination.
    Maier AG; Braks JA; Waters AP; Cowman AF
    Mol Biochem Parasitol; 2006 Nov; 150(1):118-21. PubMed ID: 16901558
    [No Abstract]   [Full Text] [Related]  

  • 35. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
    Zamboni S; Mallano A; Flego M; Ascione A; Dupuis ML; Gellini M; Barca S; Cianfriglia M
    Int J Oncol; 2008 Jun; 32(6):1245-51. PubMed ID: 18497986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpPosNeg: A positive-negative selection strategy allowing multiple cycles of marker-free engineering of the Chlamydomonas plastome.
    Jackson HO; Taunt HN; Mordaka PM; Kumari S; Smith AG; Purton S
    Biotechnol J; 2022 Oct; 17(10):e2200088. PubMed ID: 35509114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytosine deaminase as a negative selective marker for Arabidopsis.
    Perera RJ; Linard CG; Signer ER
    Plant Mol Biol; 1993 Nov; 23(4):793-9. PubMed ID: 8251632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
    Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
    Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene therapy for ovarian cancer by adenovirus-mediated transduction of cytosine deaminase gene in vitro].
    Li Q; Peng Z; Wang H; Yao Y; Zhang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):5-8. PubMed ID: 15600165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.